Court grants favorable decision to Warner Chilcott in Doryx dispute

A New Jersey court has granted a motion for preliminary injunction against Mylan ($MYL) preventing the company from launching a generic version of Doryx 150 mg before a decision is made in Warner Chilcott's ($WCRX) lawsuit against it. Warner Chilcott's suit maintains Mylan is infringing a patent covering the antibiotic. Warner Chilcott release

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.